LU86343A1 - Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren - Google Patents

Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren Download PDF

Info

Publication number
LU86343A1
LU86343A1 LU86343A LU86343A LU86343A1 LU 86343 A1 LU86343 A1 LU 86343A1 LU 86343 A LU86343 A LU 86343A LU 86343 A LU86343 A LU 86343A LU 86343 A1 LU86343 A1 LU 86343A1
Authority
LU
Luxembourg
Prior art keywords
solution
sisomicin
pharmaceutical compositions
antioxidant
compositions according
Prior art date
Application number
LU86343A
Other languages
German (de)
English (en)
French (fr)
Inventor
Eva Somfai
Katalin Kaloy
Miklos Jaray
Enikoe Kovacs
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LU86343A1 publication Critical patent/LU86343A1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU86343A 1985-03-07 1986-03-06 Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren LU86343A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU85859A HU197514B (en) 1985-03-07 1985-03-07 Process for production of injection sulution containing acid-additional salts od sysomicin
HU85985 1985-03-07

Publications (1)

Publication Number Publication Date
LU86343A1 true LU86343A1 (fr) 1986-06-24

Family

ID=10951729

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86343A LU86343A1 (fr) 1985-03-07 1986-03-06 Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren

Country Status (20)

Country Link
EP (1) EP0195114B1 (it)
JP (1) JPS61267523A (it)
CN (1) CN1010551B (it)
AU (1) AU587014B2 (it)
BE (1) BE904289A (it)
CA (1) CA1267091A (it)
DD (1) DD243208A5 (it)
DE (1) DE3577657D1 (it)
DK (1) DK165669C (it)
ES (1) ES8704078A1 (it)
GB (1) GB2171907B (it)
GR (1) GR851869B (it)
HU (1) HU197514B (it)
IL (1) IL77958A0 (it)
IT (1) IT1203543B (it)
LU (1) LU86343A1 (it)
NL (1) NL8600480A (it)
PT (1) PT82144B (it)
SE (1) SE466384B (it)
SU (1) SU1440328A3 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115671044A (zh) * 2022-11-29 2023-02-03 江苏四环生物制药有限公司 一种硫酸奈替米星注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962429A (en) * 1973-08-01 1976-06-08 Chugai Seiyaku Kabushiki Kaisha Method for reducing side effects of aminoglycoside antibiotics and composition therefor
DE2726208A1 (de) * 1977-06-10 1978-12-21 Bayer Ag 1-n-formylsisomicin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations

Also Published As

Publication number Publication date
IT1203543B (it) 1989-02-15
EP0195114B1 (en) 1990-05-16
BE904289A (fr) 1986-06-16
EP0195114A2 (en) 1986-09-24
SE466384B (sv) 1992-02-10
EP0195114A3 (en) 1988-02-03
NL8600480A (nl) 1986-10-01
SE8601050D0 (sv) 1986-03-06
HUT40758A (en) 1987-02-27
ES552709A0 (es) 1987-04-01
PT82144A (en) 1986-04-01
DK101786D0 (da) 1986-03-06
DK101786A (da) 1986-09-08
DD243208A5 (de) 1987-02-25
IT8667172A0 (it) 1986-03-04
AU5384586A (en) 1986-09-11
IL77958A0 (en) 1986-08-31
DE3577657D1 (de) 1990-06-21
JPS61267523A (ja) 1986-11-27
PT82144B (pt) 1988-02-17
SU1440328A3 (ru) 1988-11-23
DK165669B (da) 1993-01-04
GB8605629D0 (en) 1986-04-16
JPH0572365B2 (it) 1993-10-12
DK165669C (da) 1993-06-14
SE8601050L (sv) 1986-09-08
AU587014B2 (en) 1989-08-03
CN1010551B (zh) 1990-11-28
GB2171907B (en) 1989-06-14
HU197514B (en) 1989-04-28
CN85106763A (zh) 1987-02-11
GB2171907A (en) 1986-09-10
ES8704078A1 (es) 1987-04-01
GR851869B (it) 1985-12-02
CA1267091A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
DE3303860C2 (it)
DE3240177C2 (it)
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
EP2766008B1 (de) Zusammensetzung für die nasale applikation mit verbesserter stabilität
EP0166971A1 (de) Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
CH676549A5 (it)
LU86343A1 (fr) Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren
DE2606106A1 (de) Hydroxyamine, verfahren zu deren herstellung und verwendung derselben
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
EP0241804B1 (de) Konservierte Antacida-Zubereitungen
LU86115A1 (de) Metallkomplexe der bis-indolverbindungen und diese enthaltende arneimittelpraeparate
DE102004052877B4 (de) Stabile wässrige Formulierungen eines Platin-Derivats
DE2716535B2 (de) Verwendung von D-Glucaro-13-lactam
DE977478C (de) Verfahren zur Herstellung injizierbarer Insulinpraeparate mit verzoegerter Wirkung
DE2411019C2 (de) Verwendung von 1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinon oder 1-(2-Oxo-1-pyrrolidin)-4-(1-pyrrolidin)-2-butyn zur Behandlung von Glaucoma
DE69728220T2 (de) Antitumormittel mit silizium und stickstoff enthaltenden verbindungen als hauptbestandteil
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
DE3701461C2 (it)
DE19518917A1 (de) Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen
DE1595951A1 (de) Verfahren zur Herstellung von Desoxyuridinverbindungen
EP1282422A1 (de) Infusionslösungen des ciprofloxacins mit verbesserter lagerfähigkeit
EP0653210A1 (de) Intravenös verabreichbare wässrige Lösung von Sulfametrol und Trimethoprim
EP4245294A1 (de) Kathetergleitgel mit erhöhter stabilität
DE3720654A1 (de) Verfahren zur verhinderung der verfaerbung waessriger cefmenoxim-praeparate
DEF0016953MA (it)